Literature DB >> 18764856

Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals.

Eugénia Pinto1, Isabel Cristina Ribeiro, Núria Joana Ferreira, Cátia Eliana Fortes, Patrícia Alexandra Fonseca, Maria Helena Figueiral.   

Abstract

INTRODUCTION: Phospholipase and proteinase secretion in yeasts of the genus Candida has been described as a relevant virulence factor. Also, germ tube formation by Candida albicans is associated with its invasive capacity and is considered an important pathogenic mechanism.
METHODS: To link the production of hydrolytic enzymes with the capacity to produce infection, 232 clinical isolates of yeasts from the oral cavity of 140 individuals wearing removable maxillary protheses were studied. The sample was composed of 70 patients with denture-related stomatitis (DRS) and 70 individuals with normal palatal mucosa. For strains identified as C. albicans, the correlation between germ tube formation and their capacity to cause infection was studied and the presence of Candida dubliniensis was investigated. Susceptibility to fluconazole was evaluated.
RESULTS: Candida albicans was the only species producing phospholipase and germ tube. We observed a higher level of production of phospholipase in cases of infection compared with commensals. Significant differences between the two groups of C. albicans isolates were observed as to germ tube production. Only, Candida glabrata showed lower susceptibility to fluconazole.
CONCLUSION: The results reinforced the idea that C. albicans is the most frequent and can be the most pathogenic yeast in oral candidosis. However, the strains isolated from DRS patients and healthy individuals showed the same virulence factors. It seems that several virulence attributes are involved in the infective process but no single factor contributes to Candida virulence. Candida dubliniensis was absent in the oral cavity of individuals with and without DRS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18764856     DOI: 10.1111/j.1600-0714.2008.00687.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  13 in total

1.  Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples.

Authors:  Cristiane Aparecida Pereira; Anna Carolina Borges Pereira da Costa; Ana Karina Silva Machado; Miltom Beltrame Júnior; Maria Stella Amorin Costa Zöllner; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  Mycopathologia       Date:  2010-08-12       Impact factor: 2.574

2.  Comparison of the efficacy of a novel sustained release clotrimazole varnish and clotrimazole troches for the treatment of oral candidiasis.

Authors:  Rakefet Czerninski; Anna Pikovsky; Irith Gati; Michael Friedman; Doron Steinberg
Journal:  Clin Oral Investig       Date:  2014-05-28       Impact factor: 3.573

3.  Candida virulence properties and adverse clinical outcomes in neonatal candidiasis.

Authors:  Joseph M Bliss; Angela Y Wong; Grace Bhak; Sonia S Laforce-Nesbitt; Sarah Taylor; Sylvia Tan; Barbara J Stoll; Rosemary D Higgins; Seetha Shankaran; Daniel K Benjamin
Journal:  J Pediatr       Date:  2012-04-14       Impact factor: 4.406

4.  Effect of Denture-Related Stomatitis Fluconazole Treatment on Oral Candida albicans Susceptibility Profile and Genotypic Variability.

Authors:  Maria Helena Figueiral; Patrícia Fonseca; Maria Manuel Lopes; Eugénia Pinto; Teresa Pereira-Leite; Benedita Sampaio-Maia
Journal:  Open Dent J       Date:  2015-01-30

5.  Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA).

Authors:  Chaiene Evelin Zago; Sónia Silva; Paula Volpato Sanitá; Paula Aboud Barbugli; Carla Maria Improta Dias; Virgínia Barreto Lordello; Carlos Eduardo Vergani
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals.

Authors:  Zahra Seifi; Ali Zarei Mahmoudabadi; Majid Zarrin
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

7.  Soluble factors from biofilm of Candida albicans and Staphylococcus aureus promote cell death and inflammatory response.

Authors:  Kassia de Carvalho Dias; Paula Aboud Barbugli; Fernanda de Patto; Virginia Barreto Lordello; Letícia de Aquino Penteado; Alexandra Ivo Medeiros; Carlos Eduardo Vergani
Journal:  BMC Microbiol       Date:  2017-06-30       Impact factor: 3.605

8.  Generation and Characterization of Single Chain Variable Fragment against Alpha-Enolase of Candida albicans.

Authors:  Sy-Jye Leu; Yu-Ching Lee; Chi-Hsin Lee; Po-Yen Liao; Chen-Wei Chiang; Chieh-Ming Yang; Ching-Hua Su; Tsong-Yih Ou; Ko-Jiunn Liu; Hsiu-Jung Lo; Bor-Yu Tsai; Yi-Yuan Yang
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

Review 9.  Antifungal Drugs for Invasive Candida Infections (ICI) in Neonates: Future Perspectives.

Authors:  Iliana Bersani; Fiammetta Piersigilli; Bianca Maria Goffredo; Alessandra Santisi; Sara Cairoli; Maria Paola Ronchetti; Cinzia Auriti
Journal:  Front Pediatr       Date:  2019-09-20       Impact factor: 3.418

10.  Oral Candida albicans colonization in healthy individuals: prevalence, genotypic diversity, stability along time and transmissibility.

Authors:  Ângela Gerós-Mesquita; Joana Carvalho-Pereira; Ricardo Franco-Duarte; Armandino Alves; Hernâni Gerós; Célia Pais; Paula Sampaio
Journal:  J Oral Microbiol       Date:  2020-09-14       Impact factor: 5.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.